Michael Barbella, Managing Editor03.26.21
Former NuVasive Inc. CEO Gregory T. Lucier will soon be retiring from the company's Board of Directors. His retirement takes effect on May 18.
Lucier joined the board in December 2013, was elected Board chairman in May 2015, and served as CEO from May 2015 to November 2018. In his tenure, Lucier led the company's growth to more than $1 billion in net sales and oversaw the continued global expansion of the business. Under his leadership, NuVasive built a state-of-the-art manufacturing facility in West Carrollton, Ohio, where it now manufactures a majority of its spinal implants. Lucier's commitment to innovation is evident in the research and development he championed at NuVasive, such as the X360 system, Advanced Materials Science portfolio, and Pulse platform.
"I want to thank Greg for his leadership and guidance to NuVasive and the Board of Directors. His extensive medical device background and experience commercializing disruptive technology helped expand the company's key growth areas and build a strong foundation for our long-term strategy," said J. Christopher Barry, CEO of NuVasive. "Greg is a visionary leader who has committed his career to transforming the global healthcare system and reimagining the patient experience. I am grateful for the contributions Greg has made to our company, surgeons, and patients, and wish him continued success."
The NuVasive Board is currently comprised of 10 directors and includes a diverse group of current and former executives in the healthcare, medical device, and technology sectors. Lucier's retirement from the NuVasive Board will be effective at the company's annual meeting of stockholders.
"It has been a privilege to be part of a company that has transformed spine surgery and help reposition NuVasive as the leader in spine technology innovation," said Lucier. "I am extremely confident in the people of NuVasive—its employees, management team, and Board—to advance the company's strategy and fulfill its vision to change a patient's life every minute."
Lucier joined the board in December 2013, was elected Board chairman in May 2015, and served as CEO from May 2015 to November 2018. In his tenure, Lucier led the company's growth to more than $1 billion in net sales and oversaw the continued global expansion of the business. Under his leadership, NuVasive built a state-of-the-art manufacturing facility in West Carrollton, Ohio, where it now manufactures a majority of its spinal implants. Lucier's commitment to innovation is evident in the research and development he championed at NuVasive, such as the X360 system, Advanced Materials Science portfolio, and Pulse platform.
"I want to thank Greg for his leadership and guidance to NuVasive and the Board of Directors. His extensive medical device background and experience commercializing disruptive technology helped expand the company's key growth areas and build a strong foundation for our long-term strategy," said J. Christopher Barry, CEO of NuVasive. "Greg is a visionary leader who has committed his career to transforming the global healthcare system and reimagining the patient experience. I am grateful for the contributions Greg has made to our company, surgeons, and patients, and wish him continued success."
The NuVasive Board is currently comprised of 10 directors and includes a diverse group of current and former executives in the healthcare, medical device, and technology sectors. Lucier's retirement from the NuVasive Board will be effective at the company's annual meeting of stockholders.
"It has been a privilege to be part of a company that has transformed spine surgery and help reposition NuVasive as the leader in spine technology innovation," said Lucier. "I am extremely confident in the people of NuVasive—its employees, management team, and Board—to advance the company's strategy and fulfill its vision to change a patient's life every minute."
